FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

715660001: Elotuzumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3303329017 Elotuzumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3303330010 Elotuzumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Elotuzumab (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Elotuzumab (substance) Is a monoklonalt antistof-agens false Inferred relationship Some
Elotuzumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only elotuzumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Elotuzumab (substance) Inferred relationship Some 1
Elotuzumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Elotuzumab (substance) Inferred relationship Some 1
Elotuzumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Elotuzumab (substance) Inferred relationship Some 1
Product containing elotuzumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Elotuzumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start